Physician profile
Amanda Bruce
NPI 1194436980
$1,260.99
in general payments reported to CMS, 2019-2025
18 companies · $436 in 2025
The $436 reported for 2025 was more than what a typical Acute Care (Nurse Practitioner) provider received nationally (typical 2025 total: $151).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2023: $261 · 2024: $564 · 2025: $436.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,161 · Education: $99.99.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,161.00 |
| Education | $99.99 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Actelion Pharmaceuticals US, INC. | $184.83 | 2023-2025 | Opsumit, Uptravi |
| Amgen INC. | $136.33 | 2023-2025 | Repatha, Repatha |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $113.87 | 2024-2025 | Lifevest |
| Novartis Pharmaceuticals Corporation | $108.79 | 2024-2025 | |
| Esperion Therapeutics, INC. | $106.09 | 2024-2025 | Nexletol |
| Boehringer Ingelheim Pharmaceuticals, INC. | $103.95 | 2023-2025 | Jardiance |
| Bayer Healthcare Pharmaceuticals INC. | $79.20 | 2023-2024 | |
| Kiniksa Pharmaceuticals International, Plc | $62.83 | 2024 | Arcalyst |
| Daiichi Sankyo INC. | $55.75 | 2024 | Injectafer |
| Pfizer INC. | $54.76 | 2023-2024 | |
| Astrazeneca Pharmaceuticals LP | $41.00 | 2023-2025 | Farxiga |
| Novo Nordisk INC | $40.44 | 2024-2025 | Wegovy |
| Merck Sharp & Dohme LLC | $37.50 | 2023-2024 | Verquvo |
| Alnylam Pharmaceuticals INC. | $34.42 | 2025 | Amvuttra |
| E.R. Squibb & Sons, L.L.C. | $33.57 | 2025 | Camzyos |
Show all 18 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Lexicon Pharmaceuticals, INC. | $25.13 | 2023 | Inpefa |
| Inspire Medical Systems, INC. | $22.61 | 2025 | Inspire |
| Scpharmaceuticals INC. | $19.92 | 2024 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Amanda Bruce listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.